{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:33:24Z","timestamp":1759617204458},"publisher-location":"Singapore","reference-count":107,"publisher":"Springer Singapore","isbn-type":[{"type":"print","value":"9789811523847"},{"type":"electronic","value":"9789811523854"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-981-15-2385-4_2","type":"book-chapter","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T14:03:02Z","timestamp":1587564182000},"page":"11-22","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Gut Microbiota and Alimentary Tract Injury"],"prefix":"10.1007","author":[{"given":"Ye","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,23]]},"reference":[{"issue":"2","key":"2_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nrmicro.2017.158","volume":"16","author":"MX Byndloss","year":"2018","unstructured":"Byndloss MX, Baumler AJ (2018) The germ-organ theory of non-communicable diseases. Nat Rev Microbiol 16(2):103\u2013110","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"2_CR2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41579-018-0089-x","volume":"16","author":"RJ Lamont","year":"2018","unstructured":"Lamont RJ, Koo H, Hajishengallis G (2018) The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol 16(12):745\u2013759","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"2_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/QCO.0b013e3282a56a99","volume":"20","author":"J Marchesi","year":"2007","unstructured":"Marchesi J, Shanahan F (2007) The normal intestinal microbiota. Curr Opin Infect Dis 20(5):508\u2013513","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"2_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrmicro2989","volume":"11","author":"B Stecher","year":"2013","unstructured":"Stecher B, Maier L, Hardt WD (2013) \u2018Blooming\u2019 in the gut: how dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol 11(4):277\u2013284","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"2_CR5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/QCO.0000000000000196","volume":"28","author":"S Tuddenham","year":"2015","unstructured":"Tuddenham S, Sears CL (2015) The intestinal microbiome and health. Curr Opin Infect Dis 28(5):464\u2013470","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"2_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3109\/00365521.2015.1019918","volume":"50","author":"P Sipponen","year":"2015","unstructured":"Sipponen P, Maaroos HI (2015) Chronic gastritis. Scand J Gastroenterol 50(6):657\u2013667","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"2_CR7","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1158\/1055-9965.EPI-13-1057","volume":"23","author":"P Karimi","year":"2014","unstructured":"Karimi P et al (2014) Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev 23(5):700\u2013713","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2_CR8","doi-asserted-by":"crossref","unstructured":"Thrift AP, El-Serag HB (2020) Burden of gastric cancer. Clin Gastroenterol Hepatol 18(3):534\u2013542","DOI":"10.1016\/j.cgh.2019.07.045"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3109\/00365528809099131","volume":"146","author":"BJ Marshall","year":"1988","unstructured":"Marshall BJ (1988) The Campylobacter pylori story. Scand J Gastroenterol Suppl 146:58\u201366","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"12","key":"2_CR10","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1056\/NEJMcp1710945","volume":"380","author":"SE Crowe","year":"2019","unstructured":"Crowe SE (2019) Helicobacter pylori infection. N Engl J Med 380(12):1158\u20131165","journal-title":"N Engl J Med"},{"issue":"3","key":"2_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/MEG.0000000000000542","volume":"28","author":"L Wang","year":"2016","unstructured":"Wang L et al (2016) Bacterial overgrowth and diversification of microbiota in gastric cancer. Eur J Gastroenterol Hepatol 28(3):261\u2013266","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ebiom.2018.12.034","volume":"40","author":"X Liu","year":"2019","unstructured":"Liu X et al (2019) Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer. EBioMedicine 40:336\u2013348","journal-title":"EBioMedicine"},{"issue":"6","key":"2_CR13","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/gutjnl-2017-314281","volume":"67","author":"OO Coker","year":"2018","unstructured":"Coker OO et al (2018) Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut 67(6):1024\u20131032","journal-title":"Gut"},{"key":"2_CR14","doi-asserted-by":"crossref","unstructured":"Zmora N et al (2018) Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 174(6):1388\u20131405 e21","DOI":"10.1016\/j.cell.2018.08.041"},{"key":"2_CR15","first-page":"303","volume":"421","author":"GL Hold","year":"2019","unstructured":"Hold GL, Hansen R (2019) Impact of the gastrointestinal microbiome in health and disease: co-evolution with the host immune system. Curr Top Microbiol Immunol 421:303\u2013318","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"2_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.hoc.2017.01.002","volume":"31","author":"C Zhang","year":"2017","unstructured":"Zhang C et al (2017) The gastric microbiome and its influence on gastric carcinogenesis: current knowledge and ongoing research. Hematol Oncol Clin North Am 31(3):389\u2013408","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"2_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1158\/1055-9965.EPI-13-0855","volume":"23","author":"G Yu","year":"2014","unstructured":"Yu G et al (2014) Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach. Cancer Epidemiol Biomarkers Prev 23(5):735\u2013741","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2_CR18","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1128\/AEM.01675-06","volume":"73","author":"MP Tan","year":"2007","unstructured":"Tan MP et al (2007) Chronic Helicobacter pylori infection does not significantly alter the microbiota of the murine stomach. Appl Environ Microbiol 73(3):1010\u20131013","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"2_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00441-010-1125-y","volume":"344","author":"DL Merrifield","year":"2011","unstructured":"Merrifield DL et al (2011) Effect of dietary alginic acid on juvenile tilapia (Oreochromis niloticus) intestinal microbial balance, intestinal histology and growth performance. Cell Tissue Res 344(1):135\u2013146","journal-title":"Cell Tissue Res"},{"issue":"8487","key":"2_CR20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S0140-6736(86)91060-3","volume":"1","author":"BJ Marshall","year":"1986","unstructured":"Marshall BJ, Langton SR (1986) Urea hydrolysis in patients with Campylobacter pyloridis infection. Lancet 1(8487):965\u2013966","journal-title":"Lancet"},{"issue":"3","key":"2_CR21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/0016-5085(90)90957-3","volume":"99","author":"BJ Marshall","year":"1990","unstructured":"Marshall BJ et al (1990) Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology 99(3):697\u2013702","journal-title":"Gastroenterology"},{"issue":"3","key":"2_CR22","doi-asserted-by":"publisher","first-page":"e1006280","DOI":"10.1371\/journal.ppat.1006280","volume":"13","author":"H Li","year":"2017","unstructured":"Li H et al (2017) The redefinition of Helicobacter pylori lipopolysaccharide O-antigen and core-oligosaccharide domains. PLoS Pathog 13(3):e1006280","journal-title":"PLoS Pathog"},{"key":"2_CR23","doi-asserted-by":"crossref","unstructured":"Li H et al (2018) Lipopolysaccharide structural differences between western and Asian Helicobacter pylori strains. Toxins (Basel) 10(9)","DOI":"10.3390\/toxins10090364"},{"issue":"6","key":"2_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/hel.12301","volume":"21","author":"H Li","year":"2016","unstructured":"Li H et al (2016) Lipopolysaccharide structure and biosynthesis in Helicobacter pylori. Helicobacter 21(6):445\u2013461","journal-title":"Helicobacter"},{"issue":"14","key":"2_CR25","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1158\/0008-5472.CAN-16-1680","volume":"76","author":"S Backert","year":"2016","unstructured":"Backert S, Blaser MJ (2016) The role of CagA in the gastric biology of Helicobacter pylori. Cancer Res 76(14):4028\u20134031","journal-title":"Cancer Res"},{"issue":"6","key":"2_CR26","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1053\/j.gastro.2010.10.037","volume":"139","author":"MJ Blaser","year":"2010","unstructured":"Blaser MJ (2010) Helicobacter pylori and esophageal disease: wake-up call? Gastroenterology 139(6):1819\u20131822","journal-title":"Gastroenterology"},{"issue":"21","key":"2_CR27","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra0804647","volume":"361","author":"C Abraham","year":"2009","unstructured":"Abraham C, Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361(21):2066\u20132078","journal-title":"N Engl J Med"},{"issue":"10182","key":"2_CR28","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(18)33125-8","volume":"393","author":"JJ Ashton","year":"2019","unstructured":"Ashton JJ, Beattie RM (2019) Personalised therapy for inflammatory bowel disease. Lancet 393(10182):1672\u20131674","journal-title":"Lancet"},{"issue":"11","key":"2_CR29","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1136\/gut.52.11.1587","volume":"52","author":"A Sood","year":"2003","unstructured":"Sood A et al (2003) Incidence and prevalence of ulcerative colitis in Punjab. North India. Gut 52(11):1587\u20131590","journal-title":"North India. Gut"},{"issue":"9","key":"2_CR30","first-page":"1839","volume":"19","author":"J Zhao","year":"2013","unstructured":"Zhao J et al (2013) First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of \u201cwestern\u201d disease. Inflamm Bowel Dis 19(9):1839\u20131845","journal-title":"Inflamm Bowel Dis"},{"key":"2_CR31","doi-asserted-by":"crossref","unstructured":"Peery AF et al (2019) Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology 156(1):254\u2013272 e11","DOI":"10.1053\/j.gastro.2018.08.063"},{"issue":"4","key":"2_CR32","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.crohns.2013.09.001","volume":"8","author":"GC Nguyen","year":"2014","unstructured":"Nguyen GC, Chong CA, Chong RY (2014) National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States. J Crohns Colitis 8(4):288\u2013295","journal-title":"J Crohns Colitis"},{"issue":"7","key":"2_CR33","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.dld.2019.01.016","volume":"51","author":"CC Dias","year":"2019","unstructured":"Dias CC et al (2019) Hospitalization trends of the inflammatory bowel disease landscape: a nationwide overview of 16\u00a0years. Dig Liver Dis 51(7):952\u2013960","journal-title":"Dig Liver Dis"},{"issue":"9","key":"2_CR34","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S2468-1253(19)30231-6","volume":"4","author":"B Furlow","year":"2019","unstructured":"Furlow B (2019) The challenge of inflammatory bowel disease in India. Lancet Gastroenterol Hepatol 4(9):670\u2013671","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9573","key":"2_CR35","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart DC, Sandborn WJ (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369(9573):1641\u20131657","journal-title":"Lancet"},{"issue":"7758","key":"2_CR36","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price J et al (2019) Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569(7758):655\u2013662","journal-title":"Nature"},{"issue":"9","key":"2_CR37","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","volume":"13","author":"XC Morgan","year":"2012","unstructured":"Morgan XC et al (2012) Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13(9):R79","journal-title":"Genome Biol"},{"issue":"5","key":"2_CR38","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/gutjnl-2016-313235","volume":"66","author":"V Pascal","year":"2017","unstructured":"Pascal V et al (2017) A microbial signature for Crohn\u2019s disease. Gut 66(5):813\u2013822","journal-title":"Gut"},{"issue":"5","key":"2_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/gut.2003.025403","volume":"53","author":"SJ Ott","year":"2004","unstructured":"Ott SJ et al (2004) Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53(5):685\u2013693","journal-title":"Gut"},{"issue":"2","key":"2_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/gut.2005.073817","volume":"55","author":"C Manichanh","year":"2006","unstructured":"Manichanh C et al (2006) Reduced diversity of faecal microbiota in Crohn\u2019s disease revealed by a metagenomic approach. Gut 55(2):205\u2013211","journal-title":"Gut"},{"issue":"1","key":"2_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40168-019-0631-8","volume":"7","author":"JA Blakeley-Ruiz","year":"2019","unstructured":"Blakeley-Ruiz JA et al (2019) Metaproteomics reveals persistent and phylum-redundant metabolic functional stability in adult human gut microbiomes of Crohn\u2019s remission patients despite temporal variations in microbial taxa, genomes, and proteomes. Microbiome 7(1):18","journal-title":"Microbiome"},{"issue":"6","key":"2_CR42","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","volume":"66","author":"H Sokol","year":"2017","unstructured":"Sokol H et al (2017) Fungal microbiota dysbiosis in IBD. Gut 66(6):1039\u20131048","journal-title":"Gut"},{"issue":"10","key":"2_CR43","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1136\/gutjnl-2018-316250","volume":"68","author":"V Singh","year":"2019","unstructured":"Singh V et al (2019) Microbiota fermentation-NLRP3 axis shapes the impact of dietary fibres on intestinal inflammation. Gut 68(10):1801\u20131812","journal-title":"Gut"},{"issue":"10","key":"2_CR44","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","volume":"65","author":"J Sabino","year":"2016","unstructured":"Sabino J et al (2016) Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. Gut 65(10):1681\u20131689","journal-title":"Gut"},{"key":"2_CR45","doi-asserted-by":"crossref","unstructured":"Lemoinne S et al (2019) Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis. Gut 69(1):92\u2013102","DOI":"10.1016\/S0618-8278(19)30138-0"},{"issue":"1","key":"2_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/gutjnl-2016-312135","volume":"67","author":"F Imhann","year":"2018","unstructured":"Imhann F et al (2018) Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut 67(1):108\u2013119","journal-title":"Gut"},{"issue":"45","key":"2_CR47","doi-asserted-by":"publisher","first-page":"E10539","DOI":"10.1073\/pnas.1810819115","volume":"115","author":"W Shin","year":"2018","unstructured":"Shin W, Kim HJ (2018) Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip. Proc Natl Acad Sci U S A 115(45):E10539\u2013E10547","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR48","doi-asserted-by":"crossref","unstructured":"van der Post S et al (2019) Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis. Gut 68(12):2142\u20132151","DOI":"10.1136\/gutjnl-2018-317571"},{"issue":"1","key":"2_CR49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41467-018-07841-3","volume":"10","author":"Y Haberman","year":"2019","unstructured":"Haberman Y et al (2019) Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response. Nat Commun 10(1):38","journal-title":"Nat Commun"},{"issue":"1","key":"2_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-018-0604-3","volume":"7","author":"H Armstrong","year":"2019","unstructured":"Armstrong H et al (2019) Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases. Microbiome 7(1):1","journal-title":"Microbiome"},{"issue":"5","key":"2_CR51","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cell.2014.08.006","volume":"158","author":"NW Palm","year":"2014","unstructured":"Palm NW et al (2014) Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158(5):1000\u20131010","journal-title":"Cell"},{"key":"2_CR52","doi-asserted-by":"crossref","unstructured":"Svolos V et al (2019) Treatment of active Crohn\u2019s disease with an ordinary food-based diet that replicates exclusive enteral nutrition. Gastroenterology 156(5):1354\u20131367 e6","DOI":"10.1053\/j.gastro.2018.12.002"},{"issue":"4","key":"2_CR53","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1053\/j.gastro.2019.01.277","volume":"157","author":"JJ Ashton","year":"2019","unstructured":"Ashton JJ, Beattie RM (2019) Treatment of active Crohn\u2019s disease with an ordinary food-based diet that replicates exclusive enteral nutrition. Gastroenterology 157(4):1160\u20131161","journal-title":"Gastroenterology"},{"key":"2_CR54","doi-asserted-by":"crossref","unstructured":"Quince C et al (2015) Extensive modulation of the fecal metagenome in children with Crohn\u2019s disease during exclusive enteral nutrition. Am J Gastroenterol 110(12):1718\u201329; quiz 1730","DOI":"10.1038\/ajg.2015.357"},{"issue":"2","key":"2_CR55","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2018.20046","volume":"321","author":"SP Costello","year":"2019","unstructured":"Costello SP et al (2019) Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA 321(2):156\u2013164","journal-title":"JAMA"},{"issue":"10182","key":"2_CR56","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/S0140-6736(18)32592-3","volume":"393","author":"JS Hyams","year":"2019","unstructured":"Hyams JS et al (2019) Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study. Lancet 393(10182):1708\u20131720","journal-title":"Lancet"},{"key":"2_CR57","doi-asserted-by":"crossref","unstructured":"Cleary B et al (2017) Efficient generation of transcriptomic profiles by random composite measurements. Cell 171(6):1424\u20131436 e18","DOI":"10.1016\/j.cell.2017.10.023"},{"key":"2_CR58","doi-asserted-by":"crossref","unstructured":"Drossman DA (2016) Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology pii: S0016-5085(16)00223-7","DOI":"10.1053\/j.gastro.2016.02.032"},{"issue":"26","key":"2_CR59","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1056\/NEJMra1607547","volume":"376","author":"AC Ford","year":"2017","unstructured":"Ford AC, Lacy BE, Talley NJ (2017) Irritable bowel syndrome. N Engl J Med 376(26):2566\u20132578","journal-title":"N Engl J Med"},{"issue":"2","key":"2_CR60","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1017\/S0007114519000680","volume":"122","author":"G Precup","year":"2019","unstructured":"Precup G, Vodnar DC (2019) Gut Prevotella as a possible biomarker of diet and its eubiotic versus dysbiotic roles: a comprehensive literature review. Br J Nutr 122(2):131\u2013140","journal-title":"Br J Nutr"},{"issue":"8","key":"2_CR61","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/PSY.0000000000000630","volume":"80","author":"J Peter","year":"2018","unstructured":"Peter J et al (2018) A microbial signature of Psychological distress in irritable bowel syndrome. Psychosom Med 80(8):698\u2013709","journal-title":"Psychosom Med"},{"key":"2_CR62","doi-asserted-by":"crossref","unstructured":"Hugerth LW et al (2019) No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population. pii: gutjnl-2019-318717","DOI":"10.1136\/gutjnl-2019-318717"},{"key":"2_CR63","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/bs.irn.2016.08.003","volume":"131","author":"SM Collins","year":"2016","unstructured":"Collins SM (2016) The intestinal microbiota in the irritable bowel syndrome. Int Rev Neurobiol 131:247\u2013261","journal-title":"Int Rev Neurobiol"},{"key":"2_CR64","doi-asserted-by":"publisher","first-page":"e4282","DOI":"10.7717\/peerj.4282","volume":"6","author":"AH Mandarano","year":"2018","unstructured":"Mandarano AH et al (2018) Eukaryotes in the gut microbiota in myalgic encephalomyelitis\/chronic fatigue syndrome. PeerJ 6:e4282","journal-title":"PeerJ"},{"key":"2_CR65","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.3389\/fmicb.2019.01894","volume":"10","author":"Y Gu","year":"2019","unstructured":"Gu Y et al (2019) The potential role of gut mycobiome in irritable bowel syndrome. Front Microbiol 10:1894","journal-title":"Front Microbiol"},{"issue":"5","key":"2_CR66","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1136\/gutjnl-2016-313128","volume":"67","author":"SMP Bennet","year":"2018","unstructured":"Bennet SMP et al (2018) Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. Gut 67(5):872\u2013881","journal-title":"Gut"},{"issue":"8","key":"2_CR67","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1136\/gutjnl-2017-313750","volume":"66","author":"HM Staudacher","year":"2017","unstructured":"Staudacher HM, Whelan K (2017) The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut 66(8):1517\u20131527","journal-title":"Gut"},{"issue":"1","key":"2_CR68","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1172\/JCI92390","volume":"128","author":"SY Zhou","year":"2018","unstructured":"Zhou SY et al (2018) FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction. J Clin Invest 128(1):267\u2013280","journal-title":"J Clin Invest"},{"issue":"4","key":"2_CR69","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1177\/2050640617744457","volume":"6","author":"CH Wilder-Smith","year":"2018","unstructured":"Wilder-Smith CH et al (2018) Breath methane concentrations and markers of obesity in patients with functional gastrointestinal disorders. United European Gastroenterol J 6(4):595\u2013603","journal-title":"United European Gastroenterol J"},{"key":"2_CR70","doi-asserted-by":"crossref","unstructured":"Wilder-Smith CH et al (2018) Fermentable sugar ingestion, gas production, and gastrointestinal and central nervous system symptoms in patients with functional disorders. Gastroenterology 155(4):1034\u20131044 e6","DOI":"10.1053\/j.gastro.2018.07.013"},{"issue":"2","key":"2_CR71","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10620-017-4893-3","volume":"63","author":"J Valeur","year":"2018","unstructured":"Valeur J et al (2018) Exploring gut microbiota composition as an indicator of clinical response to dietary FODMAP restriction in patients with irritable bowel syndrome. Dig Dis Sci 63(2):429\u2013436","journal-title":"Dig Dis Sci"},{"issue":"4","key":"2_CR72","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/ncp.10108","volume":"33","author":"N Vakil","year":"2018","unstructured":"Vakil N (2018) Dietary fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) and gastrointestinal disease. Nutr Clin Pract 33(4):468\u2013475","journal-title":"Nutr Clin Pract"},{"issue":"10","key":"2_CR73","doi-asserted-by":"publisher","first-page":"e13675","DOI":"10.1111\/nmo.13675","volume":"31","author":"CJ Tuck","year":"2019","unstructured":"Tuck CJ et al (2019) The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome. Neurogastroenterol Motil 31(10):e13675","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"2_CR74","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/SGA.0000000000000428","volume":"42","author":"H Su","year":"2019","unstructured":"Su H et al (2019) Effects of low-FODMAPS diet on irritable bowel syndrome symptoms and gut microbiome. Gastroenterol Nurs 42(2):150\u2013158","journal-title":"Gastroenterol Nurs"},{"issue":"7","key":"2_CR75","doi-asserted-by":"publisher","first-page":"e0201410","DOI":"10.1371\/journal.pone.0201410","volume":"13","author":"TJ Sloan","year":"2018","unstructured":"Sloan TJ et al (2018) A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects. PLoS ONE 13(7):e0201410","journal-title":"PLoS ONE"},{"issue":"3","key":"2_CR76","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12325-018-0673-5","volume":"35","author":"BK Rodino-Janeiro","year":"2018","unstructured":"Rodino-Janeiro BK et al (2018) A review of microbiota and irritable bowel syndrome: future in therapies. Adv Ther 35(3):289\u2013310","journal-title":"Adv Ther"},{"key":"2_CR77","doi-asserted-by":"crossref","unstructured":"Rinninella E et al (2019) Food components and dietary habits: keys for a healthy gut microbiota composition. Nutrients 11(10)","DOI":"10.3390\/nu11102393"},{"key":"2_CR78","doi-asserted-by":"crossref","unstructured":"Rej A, Sanders DS (2018) Gluten-free diet and its \u2018cousins\u2019 in irritable bowel syndrome. Nutrients 10(11)","DOI":"10.3390\/nu10111727"},{"key":"2_CR79","doi-asserted-by":"crossref","unstructured":"Rej A et al (2019) The role of diet in irritable bowel syndrome: implications for dietary advice. J Intern Med 286(5):490\u2013502","DOI":"10.1111\/joim.12966"},{"issue":"3","key":"2_CR80","doi-asserted-by":"publisher","first-page":"307","DOI":"10.15403\/jgld.2014.1121.273.avy","volume":"27","author":"A Rej","year":"2018","unstructured":"Rej A et al (2018) Clinical application of dietary therapies in irritable bowel syndrome. J Gastrointestin Liver Dis 27(3):307\u2013316","journal-title":"J Gastrointestin Liver Dis"},{"issue":"24","key":"2_CR81","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.3748\/wjg.v25.i24.2973","volume":"25","author":"K Panacer","year":"2019","unstructured":"Panacer K, Whorwell PJ (2019) Dietary lectin exclusion: the next big food trend? World J Gastroenterol 25(24):2973\u20132976","journal-title":"World J Gastroenterol"},{"key":"2_CR82","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ctim.2019.01.010","volume":"43","author":"SL Ooi","year":"2019","unstructured":"Ooi SL, Correa D, Pak SC (2019) Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome\u2014what is the current evidence? Complement Ther Med 43:73\u201380","journal-title":"Complement Ther Med"},{"issue":"2","key":"2_CR83","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/apt.15079","volume":"49","author":"H Mitchell","year":"2019","unstructured":"Mitchell H et al (2019) Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research. Aliment Pharmacol Ther 49(2):124\u2013139","journal-title":"Aliment Pharmacol Ther"},{"key":"2_CR84","unstructured":"Konturek PC, Zopf Y (2017) Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy. MMW Fortschr Med 159(Suppl 7):1\u20135"},{"issue":"3","key":"2_CR85","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/01.JAA.0000553384.82884.b8","volume":"32","author":"E Kay","year":"2019","unstructured":"Kay E et al (2019) Nonpharmacologic options for treating irritable bowel syndrome. JAAPA 32(3):38\u201342","journal-title":"JAAPA"},{"issue":"4","key":"2_CR86","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1053\/j.gastro.2018.06.045","volume":"155","author":"JW Huaman","year":"2018","unstructured":"Huaman JW et al (2018) Effects of prebiotics vs. a diet low in FODMAPs in patients with functional gut disorders. Gastroenterology 155(4):1004\u20131007","journal-title":"Gastroenterology"},{"issue":"1","key":"2_CR87","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(17)30338-2","volume":"3","author":"PH Johnsen","year":"2018","unstructured":"Johnsen PH et al (2018) Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol 3(1):17\u201324","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"2_CR88","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1136\/gutjnl-2018-316434","volume":"67","author":"SI Halkjaer","year":"2018","unstructured":"Halkjaer SI et al (2018) Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Gut 67(12):2107\u20132115","journal-title":"Gut"},{"key":"2_CR89","doi-asserted-by":"crossref","unstructured":"De Palma G et al (2017) Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med 9(379)","DOI":"10.1126\/scitranslmed.aaf6397"},{"issue":"6","key":"2_CR90","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"2_CR91","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-micro-102215-095513","volume":"70","author":"CA Brennan","year":"2016","unstructured":"Brennan CA, Garrett WS (2016) Gut microbiota, inflammation, and colorectal cancer. Annu Rev Microbiol 70:395\u2013411","journal-title":"Annu Rev Microbiol"},{"issue":"6","key":"2_CR92","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.ccell.2018.03.004","volume":"33","author":"H Tilg","year":"2018","unstructured":"Tilg H et al (2018) The intestinal microbiota in colorectal cancer. Cancer Cell 33(6):954\u2013964","journal-title":"Cancer Cell"},{"key":"2_CR93","doi-asserted-by":"crossref","unstructured":"Kwong TNY et al (2018) Association between bacteremia from specific microbes and subsequent diagnosis of colorectal cancer. Gastroenterology 155(2):383\u2013390 e8","DOI":"10.1053\/j.gastro.2018.04.028"},{"issue":"6","key":"2_CR94","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41591-019-0458-7","volume":"25","author":"S Yachida","year":"2019","unstructured":"Yachida S et al (2019) Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med 25(6):968\u2013976","journal-title":"Nat Med"},{"issue":"4","key":"2_CR95","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-019-0406-6","volume":"25","author":"J Wirbel","year":"2019","unstructured":"Wirbel J et al (2019) Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med 25(4):679\u2013689","journal-title":"Nat Med"},{"issue":"4","key":"2_CR96","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41591-019-0405-7","volume":"25","author":"AM Thomas","year":"2019","unstructured":"Thomas AM et al (2019) Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med 25(4):667\u2013678","journal-title":"Nat Med"},{"key":"2_CR97","doi-asserted-by":"publisher","first-page":"8727","DOI":"10.1038\/ncomms9727","volume":"6","author":"G Nakatsu","year":"2015","unstructured":"Nakatsu G et al (2015) Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat Commun 6:8727","journal-title":"Nat Commun"},{"key":"2_CR98","doi-asserted-by":"publisher","first-page":"766","DOI":"10.15252\/msb.20145645","volume":"10","author":"G Zeller","year":"2014","unstructured":"Zeller G et al (2014) Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol 10:766","journal-title":"Mol Syst Biol"},{"issue":"11","key":"2_CR99","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1136\/gutjnl-2016-313498","volume":"67","author":"E Cremonesi","year":"2018","unstructured":"Cremonesi E et al (2018) Gut microbiota modulate T cell trafficking into human colorectal cancer. Gut 67(11):1984\u20131994","journal-title":"Gut"},{"key":"2_CR100","doi-asserted-by":"crossref","unstructured":"Malik A et al (2018) SYK-CARD9 signaling axis promotes gut fungi-mediated inflammasome activation to restrict colitis and colon cancer. Immunity 49(3):515\u2013530 e5","DOI":"10.1016\/j.immuni.2018.08.024"},{"key":"2_CR101","doi-asserted-by":"crossref","unstructured":"Nakatsu G et al (2018) Alterations in enteric virome are associated with colorectal cancer and survival outcomes. Gastroenterology 155(2):529\u2013541 e5","DOI":"10.1053\/j.gastro.2018.04.018"},{"key":"2_CR102","doi-asserted-by":"crossref","unstructured":"He Z, Gharaibeh RZ, Newsome RC, Pope JL, Dougherty MW, Tomkovich S, Pons B, Mirey G, Vignard J, Hendrixson DR, Jobin C (2019) Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin. Gut 68(2):289\u2013300","DOI":"10.1136\/gutjnl-2018-317200"},{"key":"2_CR103","doi-asserted-by":"crossref","unstructured":"Coleman OI et al (2018) Activated ATF6 induces intestinal dysbiosis and innate immune response to promote colorectal tumorigenesis. Gastroenterology 155(5):1539\u20131552 e12","DOI":"10.1053\/j.gastro.2018.07.028"},{"issue":"4","key":"2_CR104","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41588-019-0350-x","volume":"51","author":"S Sanna","year":"2019","unstructured":"Sanna S et al (2019) Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet 51(4):600\u2013605","journal-title":"Nat Genet"},{"issue":"7708","key":"2_CR105","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"BB Sun","year":"2018","unstructured":"Sun BB et al (2018) Genomic atlas of the human plasma proteome. Nature 558(7708):73\u201379","journal-title":"Nature"},{"key":"2_CR106","doi-asserted-by":"crossref","unstructured":"Richardson LA (2017) Evolving as a holobiont. PLoS Biol 15(2):e2002168","DOI":"10.1371\/journal.pbio.2002168"},{"key":"2_CR107","doi-asserted-by":"crossref","unstructured":"Planes S et al (2019) The Tara Pacific expedition-A pan-ecosystemic approach of the \u201c-omics\u201d complexity of coral reef holobionts across the Pacific Ocean. PLoS Biol 17(9):e3000483","DOI":"10.1371\/journal.pbio.3000483"}],"container-title":["Advances in Experimental Medicine and Biology","Gut Microbiota and Pathogenesis of Organ Injury"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-15-2385-4_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T01:35:47Z","timestamp":1666402547000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-15-2385-4_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9789811523847","9789811523854"],"references-count":107,"URL":"https:\/\/doi.org\/10.1007\/978-981-15-2385-4_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"23 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}